Victory in the Aloha State

After more than a decade of advocacy by Hawaiian patient and provider advocacy organizations, Hawaii Governor Josh Green signed HB 1864 into law on July 9, 2026. This legislation requires state-regulated health insurers to cover standard fertility preservation services for individuals facing iatrogenic infertility, including cancer patients. The new law will cover procedures such as sperm banking and egg and embryo freezing and go into effect for health plans issued or renewed in Hawaii after December 31, 2026.

Due to Hawaii’s Prepaid Health Care Act of 1974 (PHCA) – the nation’s only state employer health coverage mandate that predates federal ERISA law – coverage will reach a broader percentage of Hawaii’s population compared to other state fertility preservation laws. We estimate that more than 700,000 Hawaiians, approximately half of the state’s population, will now have fertility preservation coverage should they ever need it.

The Alliance for Fertility Preservation would like to thank every patient advocate and organization that has been fighting tirelessly for this coverage since the first Hawaii bill was introduced in 2012. We are especially grateful for the Hawaii Society of Clinical Oncology, ASCO, Fertility Institute of Hawaii, Breast Cancer Hawaii, ACS CAN, Blood Cancer United, Susan G. Komen and all of the patient advocates who bravely shared their stories throughout this long journey.

Fertility Preservation Toolkit

Thank you for your interest in our toolkits. Please read our Terms of Use carefully as we include information that applies to all our toolkits.

All toolkits are publicly available for individual use without licensing or royalty fees. Such use of toolkits is “single use,” meaning solely for the User’s research, clinical, educational, or other application. User’s email may be added to an email distribution list to receive scientific and updated information about the toolkit(s).

We encourage use of our toolkits. User agrees not to adapt, alter, amend, abridge, modify, condense, make derivative works, or translate toolkits without prior written permission from the Provider. User agrees not to sell or incorporate toolkits into materials that could be sold without prior written consent from the Provider. To inquire about permissions, please email info@a4fp.org.


Moira Kyweluk, PhD, MPH

Dr. Moira Kyweluk, PhD, MPH (she/her) is an anthropologist, public health expert, and bioethicist. Through Third Space Research, she provides clinical research, research ethics, and strategic planning support for clients in the pharmaceutical, health care, health retail, and health and wellness technology sectors. Dr. Kyweluk is a leading expert on policy and insurance coverage impacting fertility preservation in diverse populations specifically LGBTQIA+ and transgender Americans. She has applied her research expertise across the public and private sector, including the University of Pennsylvania Perelman School of Medicine, Northwestern University Kellogg School of Management, Northwestern Feinberg School Medicine, and Ann & Robert H. Lurie Children’s Hospital of Chicago, and the Children’s Hospital of Philadelphia (CHOP).

Previously a Fellow in the Penn Postdoctoral Training Program in the Ethical, Legal and Social Implications (ELSI) of Genetics and Genomics, supported by the National Human Genome Research Institute through the Department of Medical Ethics and Health Policy at the University of Pennsylvania Perelman School of Medicine, Dr. Kyweluk holds a joint PhD/MPH from the Northwestern University PhD/Master of Public Health Program in Medical Anthropology a BA in Anthropology (Honors) from Brown University.

Her work on reproductive endocrinology, ovarian reserve testing and direct-to-consumer anti-Mullerian hormone testing has been covered by outlets including Everyday Health, Technology Today, Consumer Affairs, Fertility & Sterility Dialog and published in numerous high-impact academic journals.

Dr. Kyweluk was previously a clinical research coordinator for the University of Pennsylvania Women’s Health Clinical Research Center & University of Pennsylvania Fertility Care Center overseeing clinical research and pharmaceutical trials on all aspects of reproductive medicine including in vitro fertilization and oncofertility.